No Data
Chongqing Taiji Industry(Group)Ltd (SHSE:600129) Takes On Some Risk With Its Use Of Debt
China Great Wall Securities: Research and development of substitute products for rare traditional Chinese medicine is supported, and the launch of new products is expected to accelerate.
On October 21, the National Medical Products Administration and the State Administration of Traditional Chinese Medicine jointly issued the "Notice on Supporting the Research and Development of Substitute for Endangered Rare Traditional Chinese Medicine Materials", proposing specific measures such as strengthening collaboration between industry, academia, and research, enhancing technical guidance, and accelerating review and approval.
chongqing taiji industry (600129.SH): Sodium benzylpenicillin for injection passes the generic drug consistency evaluation.
On October 28th, Chongqing Taiji Industry (600129.SH) announced that its controlling subsidiary, Southwest Pharmaceutical Co., Ltd. (referred to as Southwest Pharmaceutical), has received the "Supplementary Drug Application Approval Letter" for injection-grade Benzathine Benzylpenicillin Sodium (specifications: 0.5g, 1.0g) from the National Medical Products Administration. Southwest Pharmaceutical's injection-grade Benzathine Benzylpenicillin Sodium has passed the generic drug quality and efficacy consistency evaluation.
Chongqing Taiji's Q3 Profit Plunges 74%, Revenue Falls 16%
Chongqing Taiji Industry Appoints Chairman
Taiji Group\'s announcement on the company\'s main operating data for the third quarter of 2024
Chongqing Taiji Industry(Group) Co.,Ltd (SHSE:600129) Looks Inexpensive But Perhaps Not Attractive EnoughNo Data
No Data
